skip to main content

Antitrust matters are rarely isolated within a single state or federal agency or jurisdiction. We represent clients facing multi-dimensional antitrust challenges on the transactional, regulatory and litigation fronts, mobilizing an unmatched combination of courtroom excellence, government experience and legal, economic and academic prowess on our clients’ behalf.

Publications

Merger Review During the COVID-19 Coronavirus Outbreak

U.S. and E.U. competition agencies have announced temporary changes in their merger review procedures as a result of the COVID-19 pandemic. Significantly, the U.S. antitrust agencies will not grant any requests for early termination. Competition review and approval delays are possible on a global basis. We review developments in competition enforcement in light of the pandemic.

» more

Publications

DOJ Resolves Criminal Product Market Allocation Charge with $100 Million Penalty and Deferred Prosecution Agreement

On April 30, the Department of Justice (DOJ) announced that a Florida oncology group has agreed to pay a criminal penalty of $100 million, which is the statutory maximum amount,[1] to resolve a charge that it conspired with a competing group to enter into a product allocation scheme involving types of cancer treatments

» more

Client News

Cigna to Sell Group Life and Disability Insurance Business to New York Life in $6.3 Billion Deal

Paul, Weiss is advising Cigna Corporation on the regulatory clearance of the $6.3 billion sale of its group life and disability insurance business to New York Life.

» more

Firm News

Publications

Antitrust Month in Review – February 2020

February was a particularly active month for the Federal Trade Commission, which sued to block three mergers and settled a matter involving issues of market allocation and board interlocks. The Department of Justice also had an active month for criminal enforcement.  Meanwhile, several states and the District of Columbia lost their bid to block the Sprint-T-Mobile merger, and the Seventh Circuit issued a significant monopolization opinion.

» more

Client News

Paul, Weiss Wins Fifth Circuit Appeal for Becton, Dickinson

Paul, Weiss won a major appeal in the Fifth Circuit on behalf of client Becton, Dickinson and Company (BD) in a long-running antitrust and false advertising litigation brought by competitor Retractable Technologies, Inc. (RTI). 

» more

Awards & Recognition

Scott Barshay and Rick Rule Recognized as “Dealmakers of the Year” by The American Lawyer

Corporate partner Scott Barshay and litigation partner Rick Rule have been named American Lawyer “Dealmakers of the Year.” 

» more

Client News

Cigna Secures DOJ Clearance of $67 Billion Express Scripts Acquisition

Cigna announced that the Antitrust Division of the DOJ cleared Cigna’s $67 billion acquisition of pharmacy benefits manager Express Scripts Holding.

» more

Client News

New York Judge Dismisses SSA Price-Fixing Class Action Against Nomura

In a victory for client Nomura and other defendant banks, Paul, Weiss and other joint defense firms won the dismissal of a consolidated class action alleging that Nomura and other major global financial institutions conspired to manipulate prices in the multitrillion-dollar global market for supranational, sub-sovereign and agency (SSA) bonds. 

» more

© 2020 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy